Vaccination With a Recombinant Protein Encoding the Tumor-specific Antigen NY-ESO-1 Elicits an A2/157-165-specific CTL Repertoire Structurally Distinct and of Reduced Tumor Reactivity Than That Elicited by Spontaneous Immune Responses to NY-ESO-1-expressing Tumors-Reference-Cited by-同舟云学术

Vaccination With a Recombinant Protein Encoding the Tumor-specific Antigen NY-ESO-1 Elicits an A2/157-165-specific CTL Repertoire Structurally Distinct and of Reduced Tumor Reactivity Than That Elicited by Spontaneous Immune Responses to NY-ESO-1-expressing Tumors

Published:2009-02 Issue:2 Volume:32 Page:161-168
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Bioley Gilles,Guillaume Philippe,Luescher Immanuel,Bhardwaj Nina,Mears Gregory,Old Lloyd,Valmori Danila,Ayyoub Maha

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference27 articles.

1. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy;Scanlan;Immunol Rev,2002

2. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes;Jäger;J Exp Med,1998

3. Naturally occurring HLA-A2 restricted CD8+ T cell response to the cancer testis antigen NY-ESO-1 in melanoma patients;Valmori;Cancer Res,2000

4. Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting;Dutoit;J Clin Invest,2002

5. Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming;Valmori;Proc Natl Acad Sci USA,2007

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NY‐ESO‐1 antigen: A promising frontier in cancer immunotherapy;Clinical and Translational Medicine;2024-09

2. A Systematic Review of Potential Immunotherapies Targeting PRAME in Retinoid Resistant Oral Potentially Malignant Disorders and Oral Cancer;Current Molecular Medicine;2021-10-27

3. CpG Oligonucleotides as Vaccine Adjuvants;Methods in Molecular Biology;2020-08-22

4. Nucleic Acids as Adjuvants;Oligonucleotide-Based Drugs and Therapeutics;2018-06-22

5. In silico and cell-based analyses reveal strong divergence between prediction and observation of T-cell–recognized tumor antigen T-cell epitopes;Journal of Biological Chemistry;2017-07